NCT03484078

Brief Summary

The aim of the 6-month randomized controlled trial, with 6-month no treatment follow-up, is to examine the effects of low-magnitude vibration on muscle, physical activity, and balance in children with spastic cerebral palsy.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

March 30, 2018

Completed
10 months until next milestone

Study Start

First participant enrolled

January 23, 2019

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

January 8, 2025

Status Verified

January 1, 2025

Enrollment Period

5.1 years

First QC Date

March 13, 2018

Last Update Submit

January 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in fat concentration

    Change in fat concentration assessed using imaging techniques

    Baseline, 6 months and 12 months

Secondary Outcomes (4)

  • Change in muscle size

    Baseline, 6 months and 12 months

  • Change in physical activity

    Baseline, 1 month, 6 months, 7 months, and 12 months

  • Change in dynamic balance

    Baseline, 1 month, 6 months, 7 months, and 12 months

  • Change in static balance

    Baseline, 1 month, 6 months, 7 months, and 12 months

Study Arms (2)

Vibration Platform

EXPERIMENTAL

The vibration group will stand on a platform that emits a mild vibration 10 minutes per day for 6 months. There will also be a 6 month no-treatment period.

Device: Vibration Platform

Placebo Platform

PLACEBO COMPARATOR

The placebo group will stand on a placebo platform 10 minutes per day for 6 months. There will also be a 6 month no-treatment period.

Device: Placebo Platform

Interventions

The vibration platform will emit a mild vibration when the participant stands on it 10 minutes per day for 6 months.

Vibration Platform

The placebo platform will not vibrate when the participant stands on it 10 minutes per day for 6 months.

Placebo Platform

Eligibility Criteria

Age5 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Spastic cerebral palsy
  • Independent ambulator without an assistive device (Gross Motor Function Classification System level I or II)

You may not qualify if:

  • Prior fractures in both femurs or tibias
  • Currently taking bisphosphonates
  • Unable to stand independently
  • Orthopedic surgery on a lower extremity within the last 6 months
  • Children with pure athetoid CP
  • Baclofen pump in the abdomen
  • Botox treatment within the last year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Georgia

Athens, Georgia, 30602, United States

Location

Related Publications (1)

  • Khan OA, Singh T, Barany DA, Modlesky CM. Accuracy deficits during robotic time-constrained reaching are related to altered prefrontal cortex activity in children with cerebral palsy. J Neuroeng Rehabil. 2024 Dec 19;21(1):216. doi: 10.1186/s12984-024-01502-x.

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Christopher M Modlesky, PhD

    University of Georgia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Children with CP will be randomly assigned to a vibration or a placebo group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 13, 2018

First Posted

March 30, 2018

Study Start

January 23, 2019

Primary Completion

March 1, 2024

Study Completion

January 30, 2026

Last Updated

January 8, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations